Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Series A Common Stock, $0.0001 par value per share
-
Shares outstanding
-
31,278,271
-
Total 13F shares
-
13,776,513
-
Share change
-
-3,720,986
-
Total reported value
-
$44,920,783
-
Put/Call ratio
-
123%
-
Price per share
-
$3.26
-
Number of holders
-
69
-
Value change
-
-$15,209,275
-
Number of buys
-
34
-
Number of sells
-
30
Institutional Holders of Sagimet Biosciences Inc. - Series A Common Stock, $0.0001 par value per share (SGMT) as of Q1 2025
As of 31 Mar 2025 Sagimet Biosciences Inc. - Series A Common Stock, $0.0001 par value per share (SGMT) had 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 13,776,513 shares of stock of the company.
Largest 10 holders included Point72 Asset Management, L.P., Blue Owl Capital Holdings LP, Alyeska Investment Group, L.P., VANGUARD GROUP INC, BlackRock, Inc., BAKER BROS. ADVISORS LP, Rock Springs Capital Management LP, HHLR ADVISORS, LTD., Siren, L.L.C., and PFM Health Sciences, LP.
This table shows 69 institutional shareholders of the security as of 31 Mar 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.